Literature DB >> 11020897

Preoperative staging of periampullar cancer with US, CT, EUS and CA 19-9.

A Tomazic1, V Pegan.   

Abstract

BACKGROUND/AIMS: Several diagnostic methods are available for preoperative staging of periampullary cancers. It happens that on the basis of preoperative findings the patient is prepared for radical surgery, but during the operation the lesion turns out to be unresectable.
METHODOLOGY: We studied 43 patients operated on for periampullary cancer. Preoperatively, all patients were evaluated by ultrasonography, computed tomography, endoscopic ultrasonography and the level of carbohydrate antigen 19-9 was assessed. Statistical parameters were calculated and compared.
RESULTS: Endoscopic ultrasonography has specificity of 70.8% and positive predictive value regarding tumor resectability 55.8%. Computed tomography has a specificity of 45.8% and carbohydrate antigen 19-9 of 66.7%. Positive predictive value for computed tomography and carbohydrate antigen 19-9 is 40.6% and 52.6%, respectively. Ultrasonography is the least accurate method with specificity of 12.5% and positive predictive value 29.7%. A combined use of different diagnostic methods has higher positive predictive value, highest (65.1%) being found for the combination of endoscopic ultrasonography and carbohydrate antigen 19-9. Statistical tests showed statistically significant differences between diagnostic methods.
CONCLUSIONS: Among the diagnostic methods studied, endoscopic ultrasonography showed the highest accuracy in predicting tumor resectability. The use of either endoscopic ultrasonography and carbohydrate antigen 19-9 or computed tomography and carbohydrate antigen 19-9 is accurate enough for assessing tumor resectability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11020897

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

Review 1.  Imaging for the diagnosis and staging of periampullary carcinomas.

Authors:  R M Walsh; M Connelly; M Baker
Journal:  Surg Endosc       Date:  2003-08-15       Impact factor: 4.584

Review 2.  Molecular markers of pancreatic cancer: development and clinical relevance.

Authors:  Lucia C Fry; Klaus Mönkemüller; Peter Malfertheiner
Journal:  Langenbecks Arch Surg       Date:  2008-02-12       Impact factor: 3.445

Review 3.  Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Domenico Tamburrino; Deniece Riviere; Mohammad Yaghoobi; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-09-15

4.  The value of imaging techniques in the staging of pancreatic cancer.

Authors:  J Kulig; T Popiela; A Zajac; S Kłek; P Kołodziejczyk
Journal:  Surg Endosc       Date:  2004-12-02       Impact factor: 4.584

5.  Efficacy of multi-detector computerized tomography scan, endoscopic ultrasound, and laparoscopy for predicting tumor resectability in pancreatic adenocarcinoma.

Authors:  Mahmud Baghbanian; Hasan Salmanroghani; Ali Baghbanian; Mohsen Bakhtpour; Bijan Shabazkhani
Journal:  Indian J Gastroenterol       Date:  2013-08-28

6.  Diagnostic Accuracy of a 64-Slice Multi-Detector CT Scan in the Preoperative Evaluation of Periampullary Neoplasms.

Authors:  Shahryar Hashemzadeh; Behzad Mehrafsa; Farzad Kakaei; Reza Javadrashid; Rosa Golshan; Fatemeh Seifar; Farid Hajibonabi; Farzad Salmannezhad Khorami
Journal:  J Clin Med       Date:  2018-04-27       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.